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Abstract
The preparation and characterization of nitric oxide (NO)-releasing silica particles formed
following the synthesis of N-diazeniumdiolate-modified aminoalkoxysilanes are reported. Briefly,
an aminoalkoxysilane solution was prepared by dissolving an appropriate amount of
aminoalkoxysilane in a mixture of ethanol, methanol, and sodium methoxide (NaOMe) base. The
silane solution was reacted with NO (5 atm) to form N-diazeniumdiolate NO donor moieties on
the amino-alkoxysilanes. Tetraethoxy- or tetramethoxysilane (TEOS or TMOS) was then mixed
with different ratios of N-diazeniumdiolate-modified aminoalkoxysilane (10 – 75 mol%, balance
TEOS or TMOS). Finally, the silane mixture was added into ethanol in the presence of an
ammonia catalyst to form NO donor silica nanoparticles via a sol–gel process. This synthetic
approach allows for the preparation of NO delivery silica scaffolds with remarkably improved NO
storage and release properties, surpassing all macromolecular NO donor systems reported to date
with respect to NO payload (11.26μmol·mg−1), maximum NO release amount (357000 ppb·mg−1),
NO release half-life (253 min), and NO release duration (101 h). The N-diazeniumdiolate-
modified silane monomers and the resulting silica nanoparticles were characterized by 29Si
nuclear magnetic resonance (NMR) spectroscopy, UV-visible spectroscopy, chemiluminescence,
atomic force microscopy (AFM), gas adsorption-desorption isotherms, and elemental analysis.
Introduction
Recent studies have established that nitric oxide (NO), a diatomic free radical endogenously
produced in the body, is an important bioregulatory agent involved in multiple physiological
processes including vasodilation, neurotransmission, angiogenesis, and phagocytosis.1–4 For
example, the non-thrombogenic properties of vascular surfaces are primarily attributed to
NO generated from endothelial cells that line the inner walls of all blood vessels.2,5 Nitric
oxide derived from endothelial cells regulates blood flow and pressure, and inhibits platelet
activation and aggregation under normal conditions.5 Furthermore, the generation of NO by
phagocytic cells (e.g., macrophages) has been implicated in fighting invading
microorganisms (e.g., bacteria).6–10 Macrophages stimulated by foreign cells produce NO to
destroy such pathogens via pathways mediated by NO and its reactive derivatives (e.g.,
N2O3 and ONOO−).6,7 The astounding pace of discovery on the physiological roles of NO
demands methods for stable storage and specific delivery of NO to biological targets.
N-Bound diazeniumdiolate ions of structure 1 (where R1 and R2 are typically alkyl side
groups), adducts of NO with secondary amines, represent one of the most studied NO donor
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systems due to their straightforward synthesis and ability to generate NO spontaneously
under biological conditions.11,12 Indeed, several small molecules modified with N-
diazeniumdiolates have been employed to elucidate their potent effects on diverse NO-
mediated disease states and pathophysiological disorders including cardiovascular disease,
ischemia-reperfusion injury, and tumor progression.12,13 However, the use of such NO
donors as therapeutics has been hindered due to several factors, including poor solubility in
physiological milieu, lack of specific targeting, limited ability to deliver therapeutic
concentrations of NO, and generation of potentially toxic byproducts (e.g., diamines and
nitrosamines), all of which have circumvented their clinical application.14–16
To overcome such drawbacks, effort has been devoted to developing macromolecular NO
storage/delivery systems whereby N-diazeniumdiolate NO donors are covalently anchored
to host frameworks.16–25 Such scaffolds provide a rational means to store large quantities of
NO and readily modulate NO release kinetics. Indeed, nanoparticle-based drug delivery has
been studied extensively for increasing drug efficacy via the enhanced permeability/
retention (EPR) effect, site-specific targeting, and controlled release of drugs.26–31 Several
NO donor micro- and nanoscale materials have been developed using a range of host
macromolecules including albumin conjugates,16 polylactic-co-glycolic acid copolymers,17
polyethyleneimine microspheres,18 polymethacrylate particles,19,20 gold clusters,21,22
dendrimers,23 and silica particles.24,25 Of these, silica scaffolds provide an attractive
platform as NO delivery vehicles because of their physical and chemical versatility.32–35
The ability to form tunable porous structures of various sizes with tailored surface
functionalities has led to the use of silica nanoparticles in bioseparation and drug delivery
systems.32 In addition, the particles are easily prepared (i.e., straightforward synthesis and
isolation) and non-toxic, setting the stage for their use in nanomedicine.33–35
Zhang et al. synthesized NO-releasing fumed silica (amorphous particles with diameters of
0.2 – 0.3 μm) by grafting amine-functionalized silylation reagents onto the silica surface and
then converting the amines to N-diazeniumdiolates.24 The silica particles prepared via this
method released 0.56 μmol NO·mg−1.24 More recently, our laboratory reported an
alternative strategy for preparing NO-releasing silica particles of variable sizes (d = 20 – 500
nm), NO payloads (0.05 – 1.78 μmol·mg−1), and NO release half-lives (0.1 – 12 h).25
Briefly, the NO-releasing silica nanoparticles were synthesized via the co-hydrolysis and
condensation of aminoalkoxysilanes (NO donor precursors) and tetraalkoxysilanes (i.e.,
tetramethoxy- or tetraethoxysilane) followed by exposure to NO (5 atm, 3 d) in the presence
of sodium methoxide (NaOMe) base to form N-diazeniumdiolates (Figure 1A).25 Although
the NO release levels of the silica nanoparticles prepared in this manner were significantly
greater than small molecule and surface-grafted silica NO donor counterparts, the NO
storage was limited due to particle aggregation at high aminoalkoxysilane concentrations,25
attributed to interactions between the amines and adjacent silanols and/or other amines via
hydrogen bonding.25,36
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Herein, we report a new synthetic approach for preparing NO-releasing silica nanoparticles
with markedly improved NO storage and release capabilities. In contrast to the previous
method25 where the amine-functionalized silica particles were first synthesized and then
reacted with NO to form N-diaze-niumdiolate moieties (hereafter referred to as “post-
formation”), N-diazeniumdiolate-modified silane monomers were prepared prior to particle
construction (“pre-formation”) (Figure 1B). This approach enables the synthesis of
nanoparticles with higher concentrations of aminoalkoxysilanes and greater NO storage
capacity. Indeed, the pre-formation strategy inherently reduces particle aggregation because
the aminoalkoxysilanes are first converted to N-diazeniumdiolates, thereby avoiding
interaction of amines during silica formation. As such, the approach facilitates better access
of NaOMe and NO to the amine sites of the silane precursors and significantly greater yields
of NO per mole of aminoalkoxysilane precursor. In this work, the pre-formed N-
diazeniumdiolate-modified silanes and the resulting silica particles were characterized
by 29Si nuclear magnetic resonance (NMR) spectroscopy, UV-visible spectroscopy,




Tetraethoxysilane (TEOS), tetramethylsilane (TMS), and sodium methoxide (NaOMe) were
purchased from Fluka (Buchs, Switzerland). N-(6-Aminohexyl)aminopropyl-
trimethoxysilane (AHAP3), N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3),
(aminoethyl-aminomethyl)phenethyltrimethoxysilane (AEMP3), N-(6-
aminohexyl)aminomethyltrimethoxysilane (AHAM3), N-(2-aminoethyl)-11-
aminoundecyltrimethoxysilane (AEAUD3), and (3-trimethoxysilyl-
propyl)diethylenetriamine (DET3) were purchased from Gelest (Tullytown, PA).
Tetramethoxysilane (TMOS) was purchased from Sigma (St. Louis, MO). Methanol
(MeOH), ethanol (EtOH), toluene, and ammonia solution (NH4OH, 30 wt% in water) were
purchased from Fisher Scientific (Fair Lawn, NJ). Nitric oxide (NO, 99.5%), argon (Ar), and
nitrogen (N2) gases were obtained from Linde Gas (Morrisville, NC) or National Welders
Supply (Raleigh, NC). Other solvents and chemicals were analytical-reagent grade and used
as received. A Millipore Milli-Q UV Gradient A10 System (Bedford, MA) was used to
purify distilled water to a final resistivity of 18.2 MΩ·cm and a total organic content of ≤6
ppb.
Synthesis of N-Diazeniumdiolate-Modified Aminoalkoxysilane Monomers
An aminoalkoxy-silane solution was prepared by dissolving 10.3 mmol of AHAP3, AEAP3,
AEMP3, AHAM3, or AEAUD3 in 24 mL of EtOH and 6 mL of MeOH in the presence of
NaOMe (10.3 mmol; an equimolar amount corresponding to the secondary amine content of
the silane precursor). Since DET3 contains two secondary amine moieties, two equimolar
amounts of NaOMe (i.e., 20.6 mmol) were used. The solution was then placed into 10 mL
vials equipped with a stir bar. The vials were placed in a Parr hydrogenation bottle (200
mL), connected to an in-house NO reactor, and flushed with Ar for 5 min, followed by a
series of six charge/discharge cycles with Ar (5 atm, 6 × 10 min) to remove oxygen in the
solution. The reaction bottle was then charged with NO to 5 atm and sealed for 3 d at room
temperature while stirring. The NO gas was purified before use by passing it through a
column packed with KOH pellets for 2 h to remove trace NO degradation products. Prior to
removing the N-diazeniumdiolate-modified aminoalkoxysilane solution, unreacted NO was
purged from the chamber with Ar for 10 min. Absorption spectra were recorded using a
Perkin-Elmer Lambda 40 UV-visible spectrophotometer (Norwalk, CT) in dilute methanolic
solutions (100 μM) to confirm the formation of diazeniumdiolates bound on the amine
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nitrogen of the silane precursors. Once synthesized, the resulting alkoxysilane-derived N-
diazeniumdiolates were immediately used to prepare NO-releasing particles in EtOH/MeOH
solutions.
Preparation of NO-Releasing Silica Nanoparticles
The silane mixtures were prepared by adding 2.8 mmol of TEOS or TMOS into different
concentrations (0.32 – 8.36 mmol corresponding to 10 – 75 mol%, balance TEOS or TMOS)
of the N-diazeniumdiolated silane solutions (prepared in the previous step), and mixed for 5
min. The silane solution was then added to 5.6 – 29.1 mL of cold EtOH (adjusting the total
volume of alcoholic solvents to 30 mL) and 6 mL of cold ammonia (30 wt% in water), and
mixed vigorously for 30 min at 4 °C to minimize any thermal decomposition of N-
diazeniumdiolates. The silica precipitate was collected by centrifugation at 4000 rpm for 5
min, washed copiously with cold EtOH, dried under ambient conditions for 1 h, and then
stored in a sealed container at −20 °C until use.
Dissociation Kinetic Studies of N-Diazeniumdiolate Derivatives
To study the decomposition kinetics of the N-diazeniumdiolate-derived NO donor species
(i.e., silane monomers and silica particles), NO release was monitored in deoxygenated
phosphate-buffered saline (PBS; 0.01 M, pH 7.4) at 37 °C using a Sievers NOA 280i
chemiluminescence Nitric Oxide Analyzer (Boulder, CO). The instrument was calibrated
with air passed through a zero filter (0 ppm NO) and 27.6 ppm of NO standard gas (balance
N2, purchased from Linde Gas). Evolved NO was transported to the analyzer by a stream of
N2 (70 mL·min−1) passed through the reaction cell.
The dissociation rate constant (kobs) of N-diazeniumdiolated silane monomers was
calculated from a linear regression of the ln Cdiaz versus time plots that consistently yielded
a good linear relationship (R2 ≥ 0.995), indicating first-order kinetics. The change of N-
diazeniumdiolate content (Cdiaz) with time was determined from ,
where  and t[NO]t are the initial N-diazeniumdiolate concentration and the total amount
of NO released from time 0 to t, respectively. The “apparent” reaction order (n) of the N-
diazeniumdiolate dissociation kinetics derived from the silica scaffolds was also determined
from the slope of the lnυ versus lnCdiaz plots fitted with a linear regression (R2 ≥ 0.995),
where υ is the dissociation rate of the N-diazeniumdiolate (−dCdiaz/dt, μmol·mg−1·h−1).
Characterization of Functionalized Silica Particles
Imaging of the particles was carried out via atomic force microscopy (AFM), the silica
particles were suspended in toluene, deposited on a freshly cleaved mica surface (SPI; West
Chester, PA), and dried under ambient conditions for 3 h. Contact mode AFM images were
obtained in air using a Molecular Force Probe 3D Atomic Force Microscope (Asylum
Research; Santa Barbara, CA) controlled with a MFP-3D software running under Igor Pro
(Wavemetrics; Lake Oswego, OR). Triangular silicon nitride cantilevers with a nominal
spring constant of 0.12 N·m−1 and resonance frequency of 20 kHz (Veeco; Santa Barbara,
CA) were used to acquire height/topography images at a scan rate range of 0.5 – 2 Hz. To
determine the particle size of the silica composite materials, multiple areas of the substrate
were imaged.
Solid-state cross-polarization/magic angle spinning (CP/MAS) 29Si nuclear magnetic
resonance (NMR) spectra were obtained at 20 °C on a Bruker 360 MHz DMX spectrometer
(Billerica, MA) equipped with wide-bore magnets (triple-axis pulsed field gradient double-
resonance probes). Silica composite particles were packed into 4 mm rotors (double-
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resonance frequency of 71.548 MHz) and spun at a speed of 8.0 kHz. The chemical shifts
were determined in ppm relative to a TMS external standard.
Nitrogen adsorption/desorption isotherms were obtained at −196 °C on an ASAP 2010
Surface Area and Porosimetry Analyzer (Micromeritics Instrument; Norcross, GA). Prior to
the measurements, silica samples were degassed at 200 °C in a vacuum for 2 h. The specific
surface area (SBET) of the silica was calculated by the Brunauer-Emmett-Teller (BET)
method using the adsorption data in a relative pressure (P/P0) range of 0.75 – 0.98.
Elemental (CHN) analyses were performed by Midwest Microlab, LLC (Indianapolis, IN).
Specifically, the concentration of amines incorporated in the functionalized silica
nanoparticles was determined. Prior to the measurements, samples were calcinated at 70 °C
for 3 d to eliminate NO from the particles.
Results and Discussion
Synthesis of N-Diazeniumdiolate-Modified Silane Monomers
To prepare NO-releasing silica nanoparticles via a “pre-formation” strategy, N-
diazeniumdiolate conjugated silane monomers were first synthesized. In initial studies of the
N-diazeniumdiolate formation reaction, an aminoalkoxysilane precursor was dissolved in
ethanol and reacted with NO at high pressures (5 atm, 3 d). This synthesis represents a
typical route used to form N-diazeniumdiolate anions, which are stabilized via a neighboring
cationic amine (i.e., intramolecularly stabilized species).11 The zwitterionic NO adducts (2,
where R = alkyltrimethoxysilane, x = 2 or 6) formed under these conditions showed poor
NO addition efficiencies ranging from 4.5 to 8.1%. Zhang et al. reported that the addition of
a strong base such as sodium methoxide (NaOMe) during NO exposure promotes the
deprotonation of the secondary amine nitrogen, thereby shifting the reaction equilibrium
toward N-diazeniumdiolate formation.24 Furthermore, the sodium ion serves as a
countercation to stabilize the anionic N-diazeniumdiolate structure of 3 (see Supporting
Information). When NaOMe was employed in this work, the conversion efficiencies
increased more than 10-fold with typical yields of 54 – 100% (see below for details). Figure
2 shows structures of sodium-stabilized N-diazeniumdiolates derived from corresponding




aminohexyl)aminomethyltrimethoxysilane (AHAM3), and N-(2-aminoethyl)-11-
aminoundecyltrimethoxysilane (AEAUD3). The formation of the N-diazeniumdiolate
functional group was confirmed via UV-visible spectroscopy in the MeOH solution. These
polyamine/NO adducts exhibited λmax ranging from 248 – 253 nm, a characteristic
maximum absorption of the N-diazeniumdiolate species (data not shown).10,11 29Si NMR
analysis indicated that the presence of NaOMe did not lead to the self-condensation of N-
diazeniumdiolate-modified silane precursors during the NO addition reactions (Step 1 in
Figure 1B). Tn peaks, characteristic of organosilane polymerization11,23,24 were not
observed.
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Chemiluminescence NO measurements were employed to obtain kinetic data for the
decomposition of N-diazeniumdiolate-functionalized silanes in deoxygenated phosphate-
buffered saline (PBS; 0.01 M, pH 7.4) at 37 °C. Our findings illustrate the drastic effects of
amine derivatization on both the NO storage and release (i.e., decomposition) properties,
including the number of moles of NO generated per mole of the starting N-diazeniumdiolate
(CNO), amine to N-diazeniumdiolate conversion efficiency (%Econv), half-life of NO release
(t1/2), and rate constant (kobs) observed in N-diazeniumdiolate breakdown (Table 1).
The NO generation ratio (CNO) and NO addition efficiency (%Econv) of sodium-stabilized
N-diazeniumdiolates are significantly affected by the ligand structures bound to the
secondary amine nitrogen where the N-diazeniumdiolate NO donor moiety is formed (see
Figure 2).11,37–39 For example, N-diazeniumdiolated AEAP3 and AHAM3 exhibited a
decreased Econv of 73 and 90%, respectively, compared to Econv of ~100% for N-
diazeniumdiolated AHAP3. This result is attributed to an increase in steric hindrance as the
parent silanes (i.e., AEAP3 and AHAM3) possess shorter alkyl chain lengths from the
secondary amine nitrogens: –(CH2)2NH2 and –CH2Si(OMe)3, respectively. For the AEMP3
silane, the presence of a rigid benzyl ring adjacent to the secondary nitrogen significantly
impeded N-diazeniumdiolate formation (Econv = 58%).39 In addition to such steric
interference, the electrophilic nature of the benzyl substituent may deteriorate the amine’s
nucleophilicity, thereby further hindering N-diazeniumdiolate formation.39 Although the
parent DET3 silane has >1 secondary amines, only one N-diazeniumdiolate moiety was
formed (CNO = 2.17 and Econv = 54%). This low conversion efficiency may be attributed to
both steric hindrance and electrostatic repulsion between two N-diazeniumdiolate groups
formed on adjacent secondary amines separated by only a short ethyl (C2) chain.
Dissociation Kinetics of N-Diazeniumdiolate-Modified Silane Monomers
The half-life (t1/2) of the silane bound N-diazeniumdiolates was determined from the NO
release plots, at the time point when half the total amount of NO was liberated. The
dissociation rate constants (kobs) of N-diazeniumdiolate derivatives studied in this work
were also calculated (see Table 1). On the basis of monitoring the amount of NO release, the
concentration of N-diazeniumdiolate species (Cdiaz) at any given time may be determined.24
The dissociation kinetics of two representative N-diazeniumdiolates derived from AEAP3
and DET3 are shown in Figure 3. Plots of the natural logarithm of the N-diazeniumdiolate
concentration (ln Cdiaz) versus time yielded a linear relationship, with R2 values typically
≥0.995 for all N-diazeniumdiolates examined (indicating first-order kinetic behaviors in all
cases).37,38 It is well-known that the decomposition of N-diazeniumdiolates follows proton-
derived first-order kinetics.11,38 As the pH of the solution becomes more basic, the
decomposition rate of N-diazeniumdiolates decreases.37,38 Although most potential
applications for N-diazeniumdiolates would be at physiological pH, the dissociation rate
dependence on pH is of interest for practical reasons. Of note, N-diazeniumdiolates stability
at high pH represents a useful means for manipulating nanoparticles, for example, without
loss of NO release during preparation, modification, and storage.38 The polyamine-derived
Shin and Schoenfisch Page 6













N-diazeniumdiolated silanes exhibited a wide range of t1/2 (3 to 210 min) and kobs (4.58 ×
10−5 to 5.41 × 10−3 s−1), depending on the stability of the N-diazeniumdiolate structures in
the reaction media.11,40
Scheme 1 illustrates the structural stability and dissociation pathway of diamine-based NO
adducts (i.e., N-diazeniumdiolated AHAP3, AEAP3, AEMP3, AHAM3, and AEAUD3).
Initially, the high basicity of the primary amines (pKa = 9.73 – 11.02)41 on these N-
diazeniumdiolate derivatives leads to protonation of the primary nitrogen site in 3 to yield
4.38 In addition to the formation of sodium salt derivatives, N-diazeniumdiolate anions may
be stabilized with an intramolecular ammonium cation via hydrogen bonding, yielding a
resonance structure 5. The short alkyl length between primary and secondary nitrogens for
AEAP3-, AEMP3-, and AEAUD3-derived N-diazeniumdiolates (C2) would facilitate
hydrogen bonding, thereby leading to relatively long half-lives (i.e., t1/2 = 114 – 210 min)
and slow dissociation rates (i.e., kobs = 4.58 – 8.86 × 10−5 s−1). However, such effect was
not observed for N-diazeniumdiolates derived from AHAP3 and AHAM3, where the
cationic primary amine is six carbons (C6) removed from the N-diazeniumdiolate group,
resulting in fast decomposition kinetics (i.e., t1/2 = 3 and 9 min, and kobs = 1.12 and 5.41 ×
10−3 s−1, respectively). The rapid decrease in stability with increasing the chain length is
attributed to the decreasing influence of hydrogen bonding in 5.38 Upon protonating the
secondary nitrogen of 5 (conjugated with the N-diazeniumdiolate moiety) to form 6, NO is
liberated. When comparing of N-diazeniumdiolate-modified AEAUD3 and AEAP3,
AEAUD3 is characterized by a longer t1/2 (176 vs. 114 min, respectively). The longer NO
release may be the result of the increased hydrophobicity for AEAUD3 imparted by the
bulky undecyl (C11) chain between the secondary nitrogen and trimethoxysilane ligand.40
Similarly, structures 7 and 8 (where R = propyltrimethoxysilane, x = 2) are representatives
of the N-diazeniumdiolate forms and hydrogen bonding interactions that are possible for
triamines such as DET3.40 Two different structures of the N-diazeniumdiolate derived from
the parent DET3 silane contribute to the biphasic character (i.e., two distinct linear regions)
in the dissociation kinetic plot (see Figure 3B). The more stable structure of 8 engaged in
two hydrogen bonding interactions is responsible for the slower dissociation rate (kobs = 6.8
× 10−6 s−1) observed from 5 to 90 h. Based on the total NO amount released from the DET3-
based N-diazeniumdiolate derivative, it was estimated that approximately 64 and 36% of
dissociation reactions were attributed to structures 7 and 8, respectively.
Synthesis and Characterization of Functionalized Silica Scaffolds
Nitric oxide-releasing silica nanoparticles were synthesized by mixing the N-
diazeniumdiolate-modified silane prepared previously with different ratios of a
tetraalkoxysilane (i.e., tetraethoxy- or tetramethoxysilane, TEOS or TMOS) in the presence
of an ammonia catalyst. Since the sol–gel process for silica polymerization was carried out
under strongly basic conditions (pH >12), N-diazeniumdiolate moieties conjugated on the
silanes were preserved without serious deterioration (see below for details). Furthermore, the
synthesis of N-diazeniumdiolate NO donors prior to silica construction enabled the
formation of particles with superior NO storage and release ability. Particle aggregation was
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reduced due to decreased hydrogen bonding interactions between amines by synthesizing N-
diazeniumdiolate-modified silanes prior to silica polymerization.
Control over both the structure and concentration of the N-diazeniumdiolate-modified silane
precursors allowed for the preparation of NO donor silica nanoparticles of widely varying
size and NO release properties. As summarized in Table 2, the size of the silica
nanoparticles was tunable by varying the type and concentration of N-diazeniumdiolated
silane derivatives used, and ranged from 21 to 151 nm in diameter. Some example AFM
images of NO-releasing silica particles are shown in Figure 4. In general, as the mol% of N-
diazeniumdiolated silane was increased, the diameter of the particle decreased (e.g., 46 ± 5
to 21 ± 2 nm in diameter for 35 to 75 mol% N-diazeniumdiolated AHAM3 silica). Recent
work suggests that the size of nanodelivery vehicles is particularly important in determining
cellular/tissue uptake and accumulation, with 20 to 100 nm (diameter) particles being
optimal.26,42,43 Most NO-releasing silica nanoparticles described herein fit this range.
Solid-state 29Si NMR spectroscopy was used to (1) confirm the incorporation of N-
diazeniumdiolate-modified aminoalkyl functionalities within the silica network, (2) calculate
the surface coverage of such ligands, and (3) determine the degree of silica polymerization
(condensation.44,45 Cross polarization and magic angle spinning (CP/MAS) NMR
techniques were employed to increase the signal resolution and sensitivity of the silicon
atoms in proximity to protons.45 The spectra for NO donor functionalized silica
nanoparticles prepared from 35 to 75 mol% of N-diazeniumdiolated AHAM3 (balance
TEOS) are shown in Figure 5, and positions and relative intensities of peaks are detailed in
Table 3. The chemical environments of silicon atoms in the spectra may be characterized
into two distinctive groups (i.e., Qn and Tn structures). Traditionally, the peaks at −90, −98,
and −108 ppm are assignedto Q2 (geminal silanol; –O2Si(OH)2), Q3 (single silanol; –
O3Si(OH)), and Q 4 (siloxane; –O4Si) structures, respectively, indicating the inorganic
networks of the silica (Figure 5B).44,45 Peaks at chemical shifts of approximately −56, −64,
and −73 ppm are representatives of silicon atoms connected to T1 (–OSi(OH)2R), T 2 (–
O2Si(OH)R), and T3 (–O3SiR) structures, respectively (where R is an N-diazeniumdiolate-
conjugated aminohexylamino-methyl group).44,45 The presence of Tn bands suggests the
existence of covalent linkages between the organic group and the silica backbone (i.e., Si–C
bridges).
As the N-diazeniumdiolate-modified AHAM3 content was increased from 35 to 75 mol%,
the surface coverage of such ligands [SC = (T1 + T2 + T3)/(−T1 + T2 + T3 + Q2 + Q3)]45,46
increased from 41 to 77% (Figure 5C). The ligand immobilization efficiency (Eimmo),
defined as the ratio of %SC and N-diazeniumdiolate-modified AHAM3 concentration (mol
%) incorporated in the starting sol,25 was 1.02 – 1.18, indicating effective immobilization of
the NO-donor functional groups. Furthermore, the stability of the silica structures was
assessed by determining the degree of condensation (%DC) according to the following
equation47,48
(Eq. 1)
where qn represents the relative intensity (I) of the Qn or Tn species, and f refers to the
connectivity of the silane monomer, determined by the number of reactive alkoxy sites (i.e.,
f = 4 and 3 for Qn and Tn structures, respectively). The %DC of N-diazeniumdiolated
AHAM3 silica particles slightly decreased from 75.6 to 72.5 as the concentration of the NO
donor-modified silanes was increased from 35 to 75 mol%. However, the overall degree of
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condensation for these inorganic-organic hybrid silica remained similar to that of TEOS
alone (%DC = 78.7), indicating that the presence of the bulky organic groups does not
significantly compromise the stability of the resulting silica networks. Of note, the
integration and quantitative analyses of these structures are complicated because the
intensity of each peak depends on the efficiency of cross polarization and the proton
relaxation time.49
As determined via nitrogen adsorption-desorption isotherms,45 the N-diazeniumdiolate-
modified silica was nonporous with surface areas (SBET) of only 10 – 20 m2·g−1 (at p/p0 =
0.75 – 0.98). Such low surface areas were expected based on previous work. Shin et al.,25
Sayari and Hamoudi,34 and Stein et al.35 have each characterized organically-modified silica
synthesized by the co-condensation method indicated highly dense, nonporous, and
amorphous structures.
Nitric Oxide Release Characteristics
Nitric oxide storage and release properties of silica nanoparticles prepared via the pre-
formation strategy were evaluated under physiological conditions (PBS; pH 7.4 at 37 °C) as
a function of N-diazeniumdiolated aminoalkoxy- and tetraalkoxysilane structure and
concentration. The NO release profiles of two representative silica nanoparticles (40 mol%
DET3/NO, balance TMOS, and 55 mol% AHAM3/NO, balance TEOS) are shown in Figure
6. These representative particles illustrate the drastic effects of silica composition on NO
release properties, including the total amount of NO (t[NO]), half-life of NO release (t1/2),
maximum concentration of NO release ([NO]m), time necessary to reach [NO]m (tm), and
NO release duration (td). The NO release properties for a series of N-diazeniumdiolate-
modified silica nanoparticles prepared by the pre-formation approach are summarized in
Table 2. Both the NO payload and release characteristics were significantly affected by the
concentration and chemical identity of the N-diazeniumdiolate-modified silanes (derived
from parent silanes of AHAP3, AEAP3, AEMP3, DET3, AHAM3, and AEAUD3) and
backbone silanes (i.e., TEOS and TMOS) used to prepare the silica nanoparticles.
Both t[NO] and [NO]m of the silica particles synthesized by the pre-formation strategy were
markedly increased compared to the silica prepared by the post-formation method25 at
identical aminoalkoxysilane concentrations (Table 2). For example, t[NO] and [NO]m for 10
mol% AHAP3 silica (balance TEOS) were increased from 0.38 to 0.56μmol·mg−1 and 370
to 3400 ppb·mg−1 for the post- and pre-formation strategies, respectively. For 17 mol%
AEAP3 silica, similar trends in t[NO] and [NO]m were observed between the post- and pre-
formation approaches. The elevated quantities of NO release are attributed to a more
homogeneous distribution of the N-diazeniumdiolate NO donors throughout the silica
particle, as depicted in Figure 1B. More importantly, the pre-formation approach enabled the
synthesis of particles containing AHAP3 and AEAP3 concentrations up to 45 mol% without
aggregation, resulting in concomitant increases in t[NO] and [NO]m of 3.77 and 1.66
μmol·mg−1, and 21700 and 1300 ppb·mg−1, respectively (Table 2 and Supporting
Information).
In the previous post-formation synthesis of NO-releasing nanoparticles,25 the utility of
TMOS as a backbone silane was evaluated as a strategy for increasing the
aminoalkoxysilane concentration as the rate of TMOS hydrolysis is faster than TEOS.50,51
Indeed, the accelerated hydrolysis and condensation reactions (i.e., rapid production and
consumption of silanols) via TMOS enabled the use of aminoalkoxysilane sol concentrations
up to 77 and 87 mol% for AHAP3 and AEAP3, respectively.25 However, elemental analysis
indicated that the levels of aminoalkoxy ligands (Camine) in the formed silica particles were
not proportional to the aminoalkoxysilane concentrations (mol%) in the starting sol (Table
4). For example, while Camine of 77 mol% AHAP3/TMOS silica prepared by the post-
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formation route was 1.72 μmol·mg−1,25 Camine for 45 mol% AHAP3/TEOS silica
synthesized by the pre-formation method was 1.91 μmol·mg−1. The less efficient
immobilization of AHAP3 via the post-formation approach is attributed to the divergent
hydrolytic polycondensation rates for AHAP3 and TMOS.25 Others have reported
previously importance of synchronizing the hydrolysis and condensation rates of bi- and
multicomponent silane systems in preparing well-ordered, porous silica materials with
homogeneous distribution of active functionalities.50–53
Silica nanoparticles prepared using N-diazeniumdiolated AHAM3 exhibited unprecedented
NO storage capacity (up to t[NO] = 11.20μmol·mg−1), surpassing all macromolecular NO
donors reported to date.16–25 The use of AHAM3 allowed for the synthesis of silica with N-
diazeniumdiolated AHAM3 concentrations up to 75 mol% while maintaining high amine
ligand immobilization efficiencies up to Camine = 6.48 μmol·mg−1 (see Tables 2 and 4). As
expected, increasing the mol% of AHAM3 from 35 to 75 mol% (balance TEOS) led to a
corresponding increase in the NO release characteristics (e.g., t[NO] increased from 4.25 to
11.20μmol·mg−1). The NO release from AHAM3-based silica nanoparticles was
characterized by a significantly initial burst of NO ([NO]m = 106000 – 321000 ppb·mg−1)
and short NO release half-life (~4 min). Such bolus release of NO indicated that AHAM3
silica represents a nanoparticle system capable of delivering the micromolar levels of NO
required to serve as an antibacterial or anti-cancer agent.6–10 In contrast, N-
diazeniumdiolated DET3 (TMOS) silica may prove beneficial as a vasodilatory agent where
pico- to nanomolar levels of NO are required for extended periods (e.g., days). For example,
t[NO], [NO]m, t1/2, and td for 40 mol% DET3 are 6.25 μmol·mg−1, 12400 ppb·mg−1, 95
min, and 101 h, respectively. Studies evaluating the effects of nanoparticles that release NO
at different rates and amounts are currently underway for multiple pharmacological
indicators.
The NO release characteristics of N-diazeniumdiolate-modified silica nanoparticles prepared
via the pre-formation strategy are significantly expanded compared to both small molecule
N-diazeniumdiolates and the silica prepared by the post-formation method. The greatest
t[NO], 11.26 μmol·mg−1, was achieved with 75 mol% AHAM3 (TMOS) silica. Such NO
release is a concentration roughly 6 times greater than that achieved with 77 mol% AHAP3
(TMOS) silica (t[NO] = 1.78 μmol·mg−1) prepared by the post-formation manner.25 The
greatest td was 101 h for 40 mol% DET (TMOS) silica, a value significantly longer than the
previous maximum (td = 15 h for 17 mol% AEAP3 (TEOS) synthesized by post-formation).
Macromolecular NO Release Kinetics
The “apparent” reaction orders (n) of the N-diazeniumdiolate-modified silica nanoparticles
were determined under physiological conditions from the slope of the lnυ – lnCdiaz plots
fitted with a linear regression (R2 ≥ 0.995).24 The term “apparent” refers to the reaction
orders of compounds (i.e., silica) having limited solubility in PBS (heterogeneous
suspensions) and therefore not exhibiting classical homogeneous kinetic behavior.24 As
illustrated in Figure 7A, the “apparent” n for 35 mol% N-diazeniumdiolated AHAM3 silica
nanoparticles was calculated to be 1.61, a significant deviation from 1, indicating the
dissociation of N-diazeniumdiolates immobilized in the silica scaffold departs from the
typical first-order kinetics. The considerable deviation from the fitting line observed at the
initial dissociation events is attributed to water uptake/hydration of the particles in aqueous
solution.24 The increased reaction order may be attributed to elevated local pH. As N-
diazeniumdiolate dissociation proceeds, free secondary amines are generated that
concomitantly increase the pH of the particles. As would be expected, the “apparent”
reaction orders of the silica nanoparticles increased from 1.61 to 1.94 (Figure 7B) upon
increasing the concentration of N-diazeniumdiolate-modified AHAM3 silanes from 35 to 75
mol%, respectively.
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The synthesis of NO-releasing silica nanoparticles represents an important step toward
developing NO storage and delivery scaffolds for pharmacological applications. In contrast
to the previous post-formation method25 in which the amine-functionalized silica particles
were first synthesized and then reacted with NO to form N-diazeniumdiolate NO donor-
modified silica, N-diazeniumdiolate-modified silane monomers were synthesized prior to
particle formation. Such “pre-formation” approach enables the synthesis of nanoparticles
with greater concentrations of aminoalkoxysilanes, and thus remarkably improved NO
storage and release capabilities. As demonstrated herein, control over both the structure and
concentration of N-diazeniumdiolate-modified aminoalkoxy- and tetraalkoxysilane
precursors allows for the preparation of NO delivery silica scaffolds of variable sizes (d = 21
– 161 nm) and NO release properties (e.g., NO payloads of 0.50 – 11.26μmol·mg−1,
maximum NO concentrations of 400 – 357000 ppb·mg−1, half-lives of 3 – 253 min, and NO
release durations of 6 – 101 h). Silica nanoparticles prepared via the pre-formation approach
exhibit both increased NO payload and NO release duration up to 6.3 and 6.7 times greater,
respectively, than silica synthesized via post-formation method.25 Future studies aim to label
silica nanoparticles with fluorescent dyes such as fluorescein isothiocyanate (FITC) to
enable particle imaging/tracking.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic of N-diazeniumdiolate-modified silica nanoparticles as NO delivery scaffolds
synthesized via two different routes: (A) post-formation; and, (B) pre-formation strategies.
Represented are example syntheses using tetraethoxysilane (TEOS) and N-(6-
aminohexyl)aminopropyltrimethoxysilane (AHAP3) as tetraalkoxy- and aminoalkoxysilane
precursors, respectively.
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Structures of sodium-stabilized N-diazeniumdiolate ions derived from corresponding parent
aminoalkoxysilanes of (A) N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3); (B)
N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3); (C)
(aminoethylaminomethyl)phenethyltrimethoxysilane (AEMP3); (D) (3-
trimethoxysilyl)diethylenetriamine (DET3); (E) N-(6-
aminohexyl)aminomethyltrimethoxysilane (AHAM3); and, (F) N-(2-aminoethyl)-11-
aminoundecyltrimethoxysilane (AEAUD3).
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Dissociation kinetic plots of lnCdiaz – time for N-diazeniumdiolate-modified AEAP3 (A)
and DET3 (B) precursors in deoxygenated PBS (0.01 M, pH 7.4) at 37 °C. The fitting lines
(dashed red) were determined from a linear regression of the corresponding experimental
data (solid black). Inserted are plots of total NO concentration released – time for each N-
diazeniumdiolate species.
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Contact mode AFM images of (A) 45 mol% N-diazeniumdiolate-modified AHAP3, (B) 35
mol% N-diazeniumdiolated AEAP3, and (C) 45 mol% N-diazeniumdiolated AHAM3 silica
particles (all balance TEOS) on a mica surface. (D) Enlargement of a single particle from
(C).
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(A) Solid-state 29Si CP/MAS NMR spectra of functionalized silica nanocomposite materials
with various amounts of N-diazeniumdiolate-modified AHAM3: (a) 35, (b) 55, and (c) 75
mol% (balance TEOS). (B) Schematic illustration of silicon chemical environments at the
surface of N-diazeniumdiolate-conjugated AHAM3/TEOS silica nanoparticles. (C) Plot of
percent surface coverage (%SC) of functional ligands vs content of AHAM3/NO adduct
precursors loaded during the silica polymerization.
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Real-time NO release profiles (A) and total NO release amount (B) for 40 mol% N-
diazeniumdiolated DET3 (balance TMOS, solid red curves) and 55 mol% N-
diazeniumdiolated AHAM3 (balance TEOS, dashed blue curves) silica nanoparticles in
deoxygenated PBS (0.01 M, pH 7.4) at 37 °C. Inset plots (A′) and (B′) represent the
expansion of graphs (A) and (B) at <100 ppb·mg−1 NO release at extended periods and at <1
h, respectively.
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(A) Dissociation kinetic plot of ln υ – lnCdiaz for 35 mol% N-diazeniumdiolated AHAM3
silica particles (balance TEOS) in deoxygenated PBS (0.01 M, pH 7.4) at 37 °C. The fitting
line (dashed red) was determined from a linear regression of the experimental data (solid
black). (B) Plot of dissociation reaction order (n) versus N-diazeniumdiolated AHAM3
concentration loaded during the silica polymerization.
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Table 1
Dissociation characteristics of N-diazeniumdiolate-modified aminoalkoxysilane precursors in 0.01 M
phosphate-buffered saline at pH 7.4 and 37 °Ca
aminoalkoxysilaneb,c CNOd % Econve t1/2 (min) 10−5 × kobs (s−1)f
AHAP3 1.99 ~100 9 112
AEAP3 1.47 73 114 8.86
AEMP3 1.15 58 210 4.58
DET3 2.17 54 81 21.7 (0.68)g
AHAM3 1.79 90 3 541
AEAUD3 1.34 67 176 5.16
a
Values were obtained using a Sievers chemiluminescence NO analyzer (NOA280i) under deoxygenated conditions.
b
AHAP3, N-(6-aminohexyl)aminopropyltrimethoxysilane; AEAP3, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane; AEMP3,
(aminoethylaminomethyl)phenethyltrimethoxysilane; DET3, (3-trimethoxysilyl)diethylenetriamine; AHAM3, N-(6-
aminohexyl)aminomethyltrimethoxysilane; AEAUD3, N-(2-aminoethyl)-11-aminoundecyltrimethoxysilane.
c
Aminoalkoxysilanes used consist of one primary and one secondary amines except DET3, which contains one primary and two secondary amines.
d
Moles of NO generated (CNO) per mole of the starting silane-derived N-diazeniumdiolate employed. Theoretical 2.0 per mole of the secondary
amine.
e
Amine to N-diazeniumdiolate conversion efficiency (Econv) = moles of NO released/(2 × moles of secondary amine).
f
First-order rate constants (kobs) were calculated from a linear regression of the ln Cdiaz versus time plots consistently with R2 ≥ 0.995.
g
The N-diazeniumdiolate-modified DET3 precursor has two distinct kobs values obtained from 0 to 3 h and 5 to 90 h (in parenthesis), respectively
(see Figure 3B).
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